PISANI, ANTONIO
PISANI, ANTONIO
DIPARTIMENTO DI SCIENZE DEL SISTEMA NERVOSO E DEL COMPORTAMENTO
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus
2015-01-01 Schirinzi, T; Sancesario, Gm; Ialongo, C; Imbriani, P; Madeo, G; Toniolo, S; Martorana, A; Pisani, A
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression
1999-01-01 Calabresi, Paolo; Gubellini, P; Centonze, Diego; Sancesario, Giuseppe; Morello, Maria; Giorgi, M; Pisani, Antonio; Bernardi, Giorgio
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms
2020-01-01 Ghosh, P.; Imbriani, P.; Caputi, N.; Natoli, S.; Schirinzi, T.; DI Lazzaro, G.; Covington, L.; Sparks, A. D.; Salnikova, Y.; Rukavina, K.; Ray Chaudhuri, K.; Pisani, A.
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices
1996-01-01 Calabresi, Paolo; Siniscalchi, A; Pisani, Antonio; Stefani, Alessandro; Mercuri, NICOLA BIAGIO; Bernardi, Giorgio
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology
2021-01-01 Sellner, J.; Jenkins, T. M.; von Oertzen, T. J.; Bassetti, C. L.; Beghi, E.; Bereczki, D.; Bodini, B.; Cavallieri, F.; Di Liberto, G.; Helbok, R.; Macerollo, A.; Maia, L. F.; Oreja-Guevara, C.; Ozturk, S.; Rakusa, M.; Pisani, A.; Priori, A.; Sauerbier, A.; Soffietti, R.; Taba, P.; Zedde, M.; Crean, M.; Burlica, A.; Twardzik, A.; Moro, E.
A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum
1997-01-01 Calabresi, P; Centonze, D; Pisani, A; Bernardi, G
A2a receptor dysregulation in dystonia dyt1 knock-out mice
2021-01-01 D'Angelo, V.; Giorgi, M.; Paldino, E.; Cardarelli, S.; Fusco, F. R.; Saverioni, I.; Sorge, R.; Martella, G.; Biagioni, S.; Mercuri, N. B.; Pisani, A.; Sancesario, G.
Aberrant striatal synaptic plasticity in monogenic parkinsonisms
2012-01-01 Madeo, G; Martella, G; Schirinzi, T; Ponterio, G; Shen, J; Bonsi, P; Pisani, A
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis
2011-01-01 Quartarone, A; Pisani, Antonio
Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition
2017-01-01 Maltese, M.; Martella, G.; Imbriani, P.; Schuermans, J.; Billion, K.; Sciamanna, G.; Farook, F.; Ponterio, G.; Tassone, A.; Santoro, M.; Bonsi, P.; Pisani, A.; Goodchild, R. E.
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors
1997-01-01 Calabresi, Paolo; Saiardi, A; Pisani, Antonio; Baik, Jh; Centonze, Diego; Mercuri, NICOLA BIAGIO; Bernardi, Giorgio; Borrelli, E.
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism
2005-01-01 Pisani, Antonio; Diomedim, ; Ruma, ; Cianciullip, ; Florisr, ; Orlacchioa, ; Bernardig, ; Calabresip,
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine
2006-01-01 Picconi, B; Barone, I; Pisani, Antonio; Nicolai, R; Benatti, P; Bernardi, Giorgio; Calvani, M; Calabresi, Paolo
Acetylcholine-mediated modulation of striatal function
2000-01-01 Calabresi, Paolo; Centonze, Diego; Gubellini, P; Pisani, Antonio; Bernardi, Giorgio
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission
1995-01-01 Calabresi, P; De Murtas, M; Stefani, A; Pisani, A; Sancesario, G; Mercuri, N; Bernardi, G
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents
1995-01-01 Stefani, A; Pisani, A; De Murtas, M; Mercuri, N; Marciani, M; Calabresi, P
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra
1995-01-01 Mercuri, N; Bonci, A; Pisani, A; Calabresi, P; Bernardi, G
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission
2011-01-01 Tassone, A; Madeo, G; Schirinzi, T; Vita, D; Puglisi, F; Ponterio, G; Borsini, F; Pisani, A; Bonsi, P.
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway
2003-01-01 Pisani, Antonio; Bonsi, P; Centonze, Diego; Martorana, Alessandro; Fusco, F; Sancesario, Giuseppe; De Persis, C; Bernardi, Giorgio; Calabresi, Paolo
Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons
2000-01-01 Pisani, Antonio; Bonsi, P; Centonze, Diego; Calabresi, Paolo; Bernardi, Giorgio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus | 1-gen-2015 | Schirinzi, T; Sancesario, Gm; Ialongo, C; Imbriani, P; Madeo, G; Toniolo, S; Martorana, A; Pisani, A | |
| A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression | 1-gen-1999 | Calabresi, Paolo; Gubellini, P; Centonze, Diego; Sancesario, Giuseppe; Morello, Maria; Giorgi, M; Pisani, Antonio; Bernardi, Giorgio | |
| A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms | 1-gen-2020 | Ghosh, P.; Imbriani, P.; Caputi, N.; Natoli, S.; Schirinzi, T.; DI Lazzaro, G.; Covington, L.; Sparks, A. D.; Salnikova, Y.; Rukavina, K.; Ray Chaudhuri, K.; Pisani, A. | |
| A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices | 1-gen-1996 | Calabresi, Paolo; Siniscalchi, A; Pisani, Antonio; Stefani, Alessandro; Mercuri, NICOLA BIAGIO; Bernardi, Giorgio | |
| A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology | 1-gen-2021 | Sellner, J.; Jenkins, T. M.; von Oertzen, T. J.; Bassetti, C. L.; Beghi, E.; Bereczki, D.; Bodini, B.; Cavallieri, F.; Di Liberto, G.; Helbok, R.; Macerollo, A.; Maia, L. F.; Oreja-Guevara, C.; Ozturk, S.; Rakusa, M.; Pisani, A.; Priori, A.; Sauerbier, A.; Soffietti, R.; Taba, P.; Zedde, M.; Crean, M.; Burlica, A.; Twardzik, A.; Moro, E. | |
| A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum | 1-gen-1997 | Calabresi, P; Centonze, D; Pisani, A; Bernardi, G | |
| A2a receptor dysregulation in dystonia dyt1 knock-out mice | 1-gen-2021 | D'Angelo, V.; Giorgi, M.; Paldino, E.; Cardarelli, S.; Fusco, F. R.; Saverioni, I.; Sorge, R.; Martella, G.; Biagioni, S.; Mercuri, N. B.; Pisani, A.; Sancesario, G. | |
| Aberrant striatal synaptic plasticity in monogenic parkinsonisms | 1-gen-2012 | Madeo, G; Martella, G; Schirinzi, T; Ponterio, G; Shen, J; Bonsi, P; Pisani, A | |
| Abnormal plasticity in dystonia: Disruption of synaptic homeostasis | 1-gen-2011 | Quartarone, A; Pisani, Antonio | |
| Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition | 1-gen-2017 | Maltese, M.; Martella, G.; Imbriani, P.; Schuermans, J.; Billion, K.; Sciamanna, G.; Farook, F.; Ponterio, G.; Tassone, A.; Santoro, M.; Bonsi, P.; Pisani, A.; Goodchild, R. E. | |
| Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | 1-gen-1997 | Calabresi, Paolo; Saiardi, A; Pisani, Antonio; Baik, Jh; Centonze, Diego; Mercuri, NICOLA BIAGIO; Bernardi, Giorgio; Borrelli, E. | |
| Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism | 1-gen-2005 | Pisani, Antonio; Diomedim, ; Ruma, ; Cianciullip, ; Florisr, ; Orlacchioa, ; Bernardig, ; Calabresip, | |
| Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine | 1-gen-2006 | Picconi, B; Barone, I; Pisani, Antonio; Nicolai, R; Benatti, P; Bernardi, Giorgio; Calvani, M; Calabresi, Paolo | |
| Acetylcholine-mediated modulation of striatal function | 1-gen-2000 | Calabresi, Paolo; Centonze, Diego; Gubellini, P; Pisani, Antonio; Bernardi, Giorgio | |
| Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission | 1-gen-1995 | Calabresi, P; De Murtas, M; Stefani, A; Pisani, A; Sancesario, G; Mercuri, N; Bernardi, G | |
| Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents | 1-gen-1995 | Stefani, A; Pisani, A; De Murtas, M; Mercuri, N; Marciani, M; Calabresi, P | |
| Actions of glycine on non-dopaminergic neurons of the rat substantia nigra | 1-gen-1995 | Mercuri, N; Bonci, A; Pisani, A; Calabresi, P; Bernardi, G | |
| Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission | 1-gen-2011 | Tassone, A; Madeo, G; Schirinzi, T; Vita, D; Puglisi, F; Ponterio, G; Borsini, F; Pisani, A; Bonsi, P. | |
| Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway | 1-gen-2003 | Pisani, Antonio; Bonsi, P; Centonze, Diego; Martorana, Alessandro; Fusco, F; Sancesario, Giuseppe; De Persis, C; Bernardi, Giorgio; Calabresi, Paolo | |
| Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons | 1-gen-2000 | Pisani, Antonio; Bonsi, P; Centonze, Diego; Calabresi, Paolo; Bernardi, Giorgio |